NIH CRM iPSC Lines Available for Distribution

Updated June 19, 2015

NEW! The NIH Common Fund has sponsored the manufacture of a cGMP-grade iPSC line that is now available to the biomedical research community to support development of cell-based therapies. This line is available from RUCDR in both clinical and research grade versions.

For information on obtaining these or any of the cells in the table below, please contact: commstaff@dls.rutgers.edu

 

NIH CRM iPSC lines available for distribution as of April 13, 2015
RUID on label CELL LINE ID Description Parental iPSC Line Parental source cell line Gender Reprogramming method
CR0000001 NCRM-1 control N/A CD34+ cord blood MALE Episomal
CR0000003 NCRM-3 control N/A CD34+ cord blood MALE Episomal
CR0000004 NCRM-4 control N/A CD34+ cord blood FEMALE Episomal
CR0000005 NCRM-5 control N/A CD34+ cord blood MALE Episomal
CR0000006 NCRM-6 control N/A CD34+ cord blood FEMALE Episomal
CR0000007 NCRM-2 control N/A CD34+ cord blood FEMALE Episomal
CR0000008 ND2.0 control N/A fibroblast (ATCC CRL-2097) MALE Episomal
CR0000010 CY2 control N/A blood MALE Episomal
CR0000011 ND1.4 control N/A fibroblast (ATCC CRL-2097) MALE Episomal
CR0000012 NCRM5C13-iCHLN.c6 LUCIFERASE REPORTER NCRM-5 CD34+ cord blood MALE Episomal
CR0000013 NCRM5AS1-iCAGcGFP.c9 GFP REPORTER NCRM-5 CD34+ cord blood MALE Episomal
CR0000014 NCRM5AS1-iCHLN.c11 LUCIFERASE REPORTER NCRM-5 CD34+ cord blood MALE Episomal
CR0000026 T21C1 Down Syndrome N/A fibroblast (Coriell AG06872) FEMALE Retroviral
CR0000027 T21C5 Revertant cell line from T21C1 subject (normal karyotype) N/A fibroblast (Coriell AG06872) FEMALE Retroviral

The above numbers represent projections and may not all be available for distribution at the same time.  Please use the contact information at Contact Us to request details.

Rutgers University Rutgers University USC Information Sciences Institute Washington University in St.Louis National Institute of Mental Health